Novel Magnetic Resonance Imaging Tools for Hypertrophic Cardiomyopathy Risk Stratification.
T1
T2
cardiac magnetic resonance imaging
feature tracking
hypertrophic cardiomyopathy
prognosis
Journal
Life (Basel, Switzerland)
ISSN: 2075-1729
Titre abrégé: Life (Basel)
Pays: Switzerland
ID NLM: 101580444
Informations de publication
Date de publication:
30 Jan 2024
30 Jan 2024
Historique:
received:
21
12
2023
revised:
22
01
2024
accepted:
23
01
2024
medline:
24
2
2024
pubmed:
24
2
2024
entrez:
24
2
2024
Statut:
epublish
Résumé
Hypertrophic cardiomyopathy (HCM) is a common genetic disorder with a well described risk of sudden cardiac death; however, risk stratification has remained a challenge. Recently, novel parameters in cardiac magnetic resonance imaging (CMR) have shown promise in helping to improve upon current risk stratification paradigms. In this manuscript, we have reviewed novel CMR risk markers and their utility in HCM. The results of the review showed that T1, extracellular volume, CMR feature tracking, and other miscellaneous novel CMR variables have the potential to improve sudden death risk stratification and may have additional roles in diagnosis and prognosis. The strengths and weaknesses of these imaging techniques, and their potential utility and implementation in HCM risk stratification are discussed.
Identifiants
pubmed: 38398708
pii: life14020200
doi: 10.3390/life14020200
pii:
doi:
Types de publication
Journal Article
Review
Langues
eng